Farid Moinfar
Institute of Pathology
Medical University of Graz
Austria
Biography
Dr. Farid Moinfar is currently working as a professor in the Institute of Pathology at the Medical University of Graz. His research interests include Breast Pathology and Gynecopathologists. He is serving as an editorial member and reviewer in several international reputed journals. He is a member of many international affiliations. he has successfully completed his Administrative responsibilities. He has authored many research articles related to his Research interest.
Research Interest
Breast Pathology and Gynecopathologists
Publications
-
** Singer, CF; Tan, YY; Fitzal, F; Steger, GG; Egle, D; Reiner, A; Rudas, M; Moinfar, F; Gruber, C; Petru, E; Bartsch, R; Tendl, KA; Fox, D; Seifert, M; Exner, R; Balic, M; Bago-Horvath, Z; Filipits, M; Gnant, M; Austrian Breast and Colorectal Cancer Study Group Pathological Complete Response to Neoadjuvant Trastuzumab Is Dependent on HER2 / CEP17 Ratio in HER2-amplified Early Breast Cancer. Clin Cancer Res. 2017; 23 (14): 3676-3683
-
** Hefler-Frischmuth, K; Hirtl-Goergl, E; Inverter, V; Lafleur, J; Brunnmayr-Petkin, G; Moinfar, F; Hefler, L One-stop clinical assessment of risk for endometrial hyperplasia (OSCAR-Endo): a fast-track protocol for evaluating endometrial pathologies. Arch Gynecol Obstet. 2017; 295 (4): 959-964
-
** Cuppens, T; Annibali, D; Coosemans, A; Trovik, J; Ter hair, N; Colas, E; Garcia-Jimenez, A; Van de Vijver, K; Kruit carriages, RP; Brinkhuis, M; Zikan, M; Dundr, P; Huvila, J; Carpén, O; Haybaeck, J; Moinfar, F; Salvesen, HB; Stukan, M; Mestdagh, C; Twice, RP; Massager, LF; Mallmann, MR; Wardelmann, E; Mints, M; Verbist, G; Thomas, D; Gommé, E; Hermans, E; Moerman, P; Bosses, T; Amant, F Potential Targets' Analysis Reveals Dual PI3K / mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas at ENITEC Group Initiative. Clin Cancer Res. 2017; 23 (5): 1274-1285. Web of Science PubMed FullText FullText_MUG